Request Free Sample ×
Germany Herbal Medicine Market Size, Growth Outlook 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Germany Herbal Medicine Market

ID: MRFR/HC/42320-HCR
200 Pages
Satyendra Maurya
Last Updated: April 24, 2026

Germany Herbal Medicine Market Research Report By Herbal Medicine Form Outlook (Extracts, Powders, Capsules Tablets, Syrups), By Herbal Medicine Distribution Channel Outlook (Hospital Retail Pharmacies, E-Commerce), By Herbal Medicine Category Outlook (Herbal Pharmaceuticals, Herbal Functional Foods, Herbal Beauty Products, Herbal Dietary Supplements), By Herbal Medicine Type of Medicinal Plants (Marrubium Vulgare, Vaccinium Macrocarpon, Echinacea, Curcuma Longa, Camellia Sinensis, Actaea Racemose, Aloe Vera, Zingiber Officinale, Cocos Nucifera, Cinnamomum Spp, Allium Sativum) and By Herbal Medicine Source Outlook (Leaves, Root Barks, Whole Plants, Fruits) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Germany Herbal Medicine Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Chemicals and Materials, BY Form (USD Billion)
  49.     4.1.1 Extracts
  50.     4.1.2 Powders
  51.     4.1.3 Capsules & Tablets
  52.     4.1.4 Syrups
  53.   4.2 Chemicals and Materials, BY Distribution Channel (USD Billion)
  54.     4.2.1 Hospital & Retail Pharmacies
  55.     4.2.2 E-Commerce
  56.   4.3 Chemicals and Materials, BY Category (USD Billion)
  57.     4.3.1 Herbal Pharmaceuticals
  58.     4.3.2 Herbal Functional Foods
  59.     4.3.3 Herbal Beauty Products
  60.     4.3.4 Herbal Dietary Supplements
  61.   4.4 Chemicals and Materials, BY Type of Medicinal Plants (USD Billion)
  62.     4.4.1 Marrubium Vulgare
  63.     4.4.2 Vaccinium Macrocarpon
  64.     4.4.3 Echinacea
  65.     4.4.4 Curcuma Longa
  66.     4.4.5 Camellia Sinensis
  67.     4.4.6 Actaea Racemose
  68.     4.4.7 Aloe Vera
  69.     4.4.8 Zingiber Officinale
  70.     4.4.9 Cocos Nucifera
  71.     4.4.10 Cinnamomum Spp
  72.     4.4.11 Allium Sativum
  73.   4.5 Chemicals and Materials, BY Source (USD Billion)
  74.     4.5.1 Leaves
  75.     4.5.2 Root & Barks
  76.     4.5.3 Whole Plants
  77.     4.5.4 Fruits
  78. 5 SECTION V: COMPETITIVE ANALYSIS
  79.   5.1 Competitive Landscape
  80.     5.1.1 Overview
  81.     5.1.2 Competitive Analysis
  82.     5.1.3 Market share Analysis
  83.     5.1.4 Major Growth Strategy in the Chemicals and Materials
  84.     5.1.5 Competitive Benchmarking
  85.     5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  86.     5.1.7 Key developments and growth strategies
  87.       5.1.7.1 New Product Launch/Service Deployment
  88.       5.1.7.2 Merger & Acquisitions
  89.       5.1.7.3 Joint Ventures
  90.     5.1.8 Major Players Financial Matrix
  91.       5.1.8.1 Sales and Operating Income
  92.       5.1.8.2 Major Players R&D Expenditure. 2023
  93.   5.2 Company Profiles
  94.     5.2.1 Herbalife (US)
  95.       5.2.1.1 Financial Overview
  96.       5.2.1.2 Products Offered
  97.       5.2.1.3 Key Developments
  98.       5.2.1.4 SWOT Analysis
  99.       5.2.1.5 Key Strategies
  100.     5.2.2 Nature's Way (US)
  101.       5.2.2.1 Financial Overview
  102.       5.2.2.2 Products Offered
  103.       5.2.2.3 Key Developments
  104.       5.2.2.4 SWOT Analysis
  105.       5.2.2.5 Key Strategies
  106.     5.2.3 Gaia Herbs (US)
  107.       5.2.3.1 Financial Overview
  108.       5.2.3.2 Products Offered
  109.       5.2.3.3 Key Developments
  110.       5.2.3.4 SWOT Analysis
  111.       5.2.3.5 Key Strategies
  112.     5.2.4 Schwabe Pharmaceuticals (DE)
  113.       5.2.4.1 Financial Overview
  114.       5.2.4.2 Products Offered
  115.       5.2.4.3 Key Developments
  116.       5.2.4.4 SWOT Analysis
  117.       5.2.4.5 Key Strategies
  118.     5.2.5 Traditional Medicinals (US)
  119.       5.2.5.1 Financial Overview
  120.       5.2.5.2 Products Offered
  121.       5.2.5.3 Key Developments
  122.       5.2.5.4 SWOT Analysis
  123.       5.2.5.5 Key Strategies
  124.     5.2.6 Himalaya Wellness (IN)
  125.       5.2.6.1 Financial Overview
  126.       5.2.6.2 Products Offered
  127.       5.2.6.3 Key Developments
  128.       5.2.6.4 SWOT Analysis
  129.       5.2.6.5 Key Strategies
  130.     5.2.7 Dabur (IN)
  131.       5.2.7.1 Financial Overview
  132.       5.2.7.2 Products Offered
  133.       5.2.7.3 Key Developments
  134.       5.2.7.4 SWOT Analysis
  135.       5.2.7.5 Key Strategies
  136.     5.2.8 Zandu Pharmaceutical Works (IN)
  137.       5.2.8.1 Financial Overview
  138.       5.2.8.2 Products Offered
  139.       5.2.8.3 Key Developments
  140.       5.2.8.4 SWOT Analysis
  141.       5.2.8.5 Key Strategies
  142.     5.2.9 Bioforce AG (CH)
  143.       5.2.9.1 Financial Overview
  144.       5.2.9.2 Products Offered
  145.       5.2.9.3 Key Developments
  146.       5.2.9.4 SWOT Analysis
  147.       5.2.9.5 Key Strategies
  148.   5.3 Appendix
  149.     5.3.1 References
  150.     5.3.2 Related Reports
  151. 6 LIST OF FIGURES
  152.   6.1 MARKET SYNOPSIS
  153.   6.2 GERMANY MARKET ANALYSIS BY FORM
  154.   6.3 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  155.   6.4 GERMANY MARKET ANALYSIS BY CATEGORY
  156.   6.5 GERMANY MARKET ANALYSIS BY TYPE OF MEDICINAL PLANTS
  157.   6.6 GERMANY MARKET ANALYSIS BY SOURCE
  158.   6.7 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
  159.   6.8 RESEARCH PROCESS OF MRFR
  160.   6.9 DRO ANALYSIS OF CHEMICALS AND MATERIALS
  161.   6.10 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  162.   6.11 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  163.   6.12 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
  164.   6.13 CHEMICALS AND MATERIALS, BY FORM, 2024 (% SHARE)
  165.   6.14 CHEMICALS AND MATERIALS, BY FORM, 2024 TO 2035 (USD Billion)
  166.   6.15 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
  167.   6.16 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
  168.   6.17 CHEMICALS AND MATERIALS, BY CATEGORY, 2024 (% SHARE)
  169.   6.18 CHEMICALS AND MATERIALS, BY CATEGORY, 2024 TO 2035 (USD Billion)
  170.   6.19 CHEMICALS AND MATERIALS, BY TYPE OF MEDICINAL PLANTS, 2024 (% SHARE)
  171.   6.20 CHEMICALS AND MATERIALS, BY TYPE OF MEDICINAL PLANTS, 2024 TO 2035 (USD Billion)
  172.   6.21 CHEMICALS AND MATERIALS, BY SOURCE, 2024 (% SHARE)
  173.   6.22 CHEMICALS AND MATERIALS, BY SOURCE, 2024 TO 2035 (USD Billion)
  174.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  175. 7 LIST OF TABLES
  176.   7.1 LIST OF ASSUMPTIONS
  177.     7.1.1
  178.   7.2 Germany MARKET SIZE ESTIMATES; FORECAST
  179.     7.2.1 BY FORM, 2025-2035 (USD Billion)
  180.     7.2.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  181.     7.2.3 BY CATEGORY, 2025-2035 (USD Billion)
  182.     7.2.4 BY TYPE OF MEDICINAL PLANTS, 2025-2035 (USD Billion)
  183.     7.2.5 BY SOURCE, 2025-2035 (USD Billion)
  184.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  185.     7.3.1
  186.   7.4 ACQUISITION/PARTNERSHIP
  187.     7.4.1

Germany Chemicals and Materials Market Segmentation

Chemicals and Materials By Form (USD Billion, 2025-2035)

  • Extracts
  • Powders
  • Capsules & Tablets
  • Syrups

Chemicals and Materials By Distribution Channel (USD Billion, 2025-2035)

  • Hospital & Retail Pharmacies
  • E-Commerce

Chemicals and Materials By Category (USD Billion, 2025-2035)

  • Herbal Pharmaceuticals
  • Herbal Functional Foods
  • Herbal Beauty Products
  • Herbal Dietary Supplements

Chemicals and Materials By Type of Medicinal Plants (USD Billion, 2025-2035)

  • Marrubium Vulgare
  • Vaccinium Macrocarpon
  • Echinacea
  • Curcuma Longa
  • Camellia Sinensis
  • Actaea Racemose
  • Aloe Vera
  • Zingiber Officinale
  • Cocos Nucifera
  • Cinnamomum Spp
  • Allium Sativum

Chemicals and Materials By Source (USD Billion, 2025-2035)

  • Leaves
  • Root & Barks
  • Whole Plants
  • Fruits

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓